Cancer BiologyScientific ReportsPeer-reviewed
Cancer associated fibroblasts mitigate the efficacy of the combination treatment of chemotherapy and BCL-xL targeting in triple negative breast cancer cells
Lisa Nocquet, Julie Roul, Chloé C. Lefebvre…·Frédérique Souazé
This study shows that BCL-xL promotes chemotherapy resistance in TNBC cells, and CAFs reduce the effectiveness of chemotherapy combined with BCL-xL inhibition.
26 citations